Ozmosi | Carbasalate calcium Drug Profile

Product Description

Mechanisms of Action: PA Inhibitor

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: N/A

FDA Designation: *

Approval Status: Not Approved

Approved Indications: None

Known Adverse Events: None

Company: Leiden University Medical Center
Company Location:
Company CEO:
Additional Commercial Interests: None

Clinical Description

Countries in Clinic:

Active Clinical Trial Count:

Recent & Upcoming Milestones

Highest Development Phases

Phase 4: Atrial Fibrillation|Acute Coronary Syndrome|Hypertension|Stroke

Trial	Phase	Trial Status	Disease	Primary Completion Date	Latest Trial Update Date	Data Updated
PROTECT-U	P3	Recruiting	Aneurysm, Ruptured	2029-06-01	2025-05-02	Treatments
APHP240889	P3	Not yet recruiting	Embolism and Thrombosis\|Pulmonary Infarction\|Myocardial Infarction\|Pulmonary Heart Disease\|Pulmonary Embolism\|Stroke	2028-11-01
ASPIRETENSION II	P3	Active, not recruiting	Hypertension	2012-08-18	2022-03-13	Treatments
ASPIRETENSION	P3	Active, not recruiting	Arthritis, Rheumatoid\|Type 1 Diabetes\|Hypertension	2006-11-02	2022-03-12	Treatments
114180	P4	Recruiting	Stroke	2031-09-02	2025-05-02	Treatments
BA-SCAD	P4	Active, not recruiting	Unknown	2026-02-28	2025-05-02	Treatments
WOEST 3 trial	P4	Completed	Acute Coronary Syndrome\|Atrial Fibrillation	2025-02-17	2025-05-06	Treatments\|Trial Status
ASPIRETENSION	P4	Completed	Hypertension	2013-10-01	2025-02-07	Primary Endpoints
2007-004354-90	P4	Active, not recruiting	Unknown	2008-03-03	2022-03-12	Treatments

Recent News Events

Date	Type	Title
06/08/2022	PubMed	Acetylsalicylic acid use is associated with reduced risk of out-of-hospital cardiac arrest in the general population: Real-world data from a population-based study.
02/21/2020	PubMed	Successful percutaneous occlusion of a large left circumflex coronary artery fistula draining into the coronary sinus using a ventricular septal defect occluder: a case report.

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you've used PRYZM, we hope you're able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions

Session Expiring Soon

Carbasalate calcium

Alternative Names: carbasalate calcium Clinical Status: Inactive Latest Update: 2025-05-15 Latest Update Note: Clinical Trial Update